Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZOM
9726
DELISTED
Zomedica Corp.
ZOM
| $170K | ﹤0.01% |
737,532
-393,732
| -35% | -$50.2K |
|
9727
CALL
Alta Equipment Group
ALTG
$243M
| $169K | ﹤0.01% |
17,100
+3,000
| +21% | +$25.9K |
|
9728
PUT
Energy Recovery
ERII
$457M
| $169K | ﹤0.01% |
+12,400
| New | +$132K |
|
9729
CALL
Gladstone Investment Corp
GAIN
$655M
| $169K | ﹤0.01% |
16,700
+2,800
| +20% | +$26.6K |
|
|
SVM
9730
PUT
Silvercorp Metals
SVM
$2.39B
| $169K | ﹤0.01% |
+25,200
| New | +$173K |
|
9731
Zedge
ZDGE
$38.8M
| $169K | ﹤0.01% |
28,057
+13,385
| +91% | +$46K |
|
|
AMPE
9732
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $169K | ﹤0.01% |
354
+155
| +78% | +$50.8K |
|
9733
First Trust Energy AlphaDEX Fund
FXN
$363M
| $168K | ﹤0.01% |
21,197
-433,086
| -95% | -$2.97M |
|
9734
CALL
TherapeuticsMD
TXMD
$24M
| $168K | ﹤0.01% |
2,778
-10
| -0.4% | -$683 |
|
|
TEN
9735
PUT
Tsakos Energy Navigation Ltd
TEN
$1.15B
| $168K | ﹤0.01% |
+20,900
| New | +$175K |
|
|
CIO
9736
PUT
DELISTED
City Office REIT
CIO
| $167K | ﹤0.01% |
17,100
+3,600
| +27% | +$29.6K |
|
|
CPRX
9737
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
| $167K | ﹤0.01% |
50,000
+37,800
| +310% | +$127K |
|
9738
PUT
eGain
EGAN
$198M
| $167K | ﹤0.01% |
+14,100
| New | +$199K |
|
9739
CALL
SandRidge Energy
SD
$487M
| $167K | ﹤0.01% |
53,800
+32,200
| +149% | +$79K |
|
9740
PUT
Solid Biosciences
SLDB
$859M
| $167K | ﹤0.01% |
+1,467
| New | +$92.8K |
|
|
TELL
9741
PUT
DELISTED
Tellurian Inc.
TELL
| $167K | ﹤0.01% |
130,400
+41,800
| +47% | +$47.3K |
|
|
IMGN
9742
PUT
DELISTED
Immunogen Inc
IMGN
| $167K | ﹤0.01% |
25,900
-9,700
| -27% | -$56.6K |
|
|
HLMNW
9743
DELISTED
Hillman Solutions Corp. Warrant
HLMNW
| $167K | ﹤0.01% |
+74,966
| New | +$117K |
|
|
AXDX
9744
PUT
DELISTED
Accelerate Diagnostics
AXDX
| $166K | ﹤0.01% |
2,190
-1,740
| -44% | -$156K |
|
9745
Anfield US Equity Sector Rotation ETF
AESR
$248M
| $165K | ﹤0.01% |
13,853
-54
| -0.4% | -$617 |
|
9746
CALL
Aldeyra Therapeutics
ALDX
$96.5M
| $165K | ﹤0.01% |
24,000
+600
| +3% | +$4.21K |
|
9747
Peabody Energy
BTU
$2.78B
| $165K | ﹤0.01% |
68,668
+16,845
| +33% | +$27.3K |
|
9748
PUT
Cytosorbents Corp
CTSO
$24.2M
| $165K | ﹤0.01% |
20,700
-9,900
| -32% | -$82.9K |
|
|
ZAGG
9749
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $165K | ﹤0.01% |
39,704
+21,871
| +123% | +$76.6K |
|
9750
PUT
Ardelyx
ARDX
$1.21B
| $164K | ﹤0.01% |
25,400
+2,200
| +9% | +$13.1K |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.